US 9861681
Therapeutic compositions for neutralizing type I interferons, and methods of use
granted A61KA61K38/162A61P
Quick answer
US patent 9861681 (Therapeutic compositions for neutralizing type I interferons, and methods of use) held by The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases
- Grant date
- Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/162, A61P, A61P31/12, A61P37/06